通过多维结构性表征利用提高药物溶解性的预测
概括
预测药物溶解度对于开发至关重要. 新的计算模型MSCSol通过使用先进的神经网络和注意力机制分析多维分子结构来准确预测溶解度.
科学领域:
- 计算化学是一种计算化学.
- 药物发现 药物发现
- 分子建模分子建模
背景情况:
- 溶解度是一个关键的物理性质,影响小分子药物开发.
- 实验性溶解度的确定是资源密集型的,需要专门的设备和受控的条件.
- 准确的药物溶解性的计算预测是长期以来的一个研究目标.
研究的目的:
- 介绍MSCSol,一种用于预测药物溶解性的新型计算模型.
- 利用多维分子结构信息来提高预测准确度.
- 开发一种更有效,更易于使用的方法来评估药物溶解度.
主要方法:
- 将图形神经网络与几何向量感知子 (GVP-GNN) 集成在一起,以编码3D分子结构.
- 选择性内核卷积与全球和本地注意力机制的应用,用于多级特征提取.
- 利用各种分子描述符和数据增强策略用于2D和3D结构数据.
主要成果:
- MSCSol在基准和独立数据集上表现出卓越的表现.
- 废弃性研究验证了单个模型组件的有效性.
- 解释性分析确定了影响溶解性的关键原子组和亚结构.
结论:
- MSCSol提供了一种强大而准确的计算方法来预测药物溶解度.
- 该模型有效地捕获复杂的分子结构信息和更高层次的知识.
- 通过减少实验成本和时间,MSCSol有可能简化药物开发过程.
相关概念视频
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
200
Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
200
Factors Influencing Drug Absorption: Physicochemical Parameters
263
The physicochemical characteristics of drugs play a crucial role in formulating stable and bioavailable drug products. The solubility of a drug, governed by the varying pH along the GI tract and its dissociation constant (pKa), is pivotal in determining its ionization state and absorption rate. Notably, weak acids and bases remain unionized and are absorbed more rapidly.
Enhanced drug absorption can be achieved by reducing particle sizes and increasing surface areas, thereby facilitating...
Enhanced drug absorption can be achieved by reducing particle sizes and increasing surface areas, thereby facilitating...
263
Factors Influencing Drug Absorption: Drug Dissolution
468
The pharmacokinetic journey of drugs from solid oral dosage forms into systemic circulation is multifaceted. It begins with disintegration, a prerequisite ensuring a solid dosage form's subdivision into minute particles. Dissolution occurs next as these granulated entities solubilize in gastrointestinal fluids. This solubilization is crucial for the succeeding stage, permeation, which describes the traversal of the drug across the intestinal membrane and its subsequent entry into the blood...
468
Structure-Activity Relationships and Drug Design
701
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
701
Factors Affecting Dissolution: Drug pKa, Lipophilicity and GI pH
1.3K
Drug absorption within the gastrointestinal (GI) tract is a complex process influenced by several critical factors, including the site pH, the drug's dissociation constant (pKa), and the drug's lipophilicity. The GI tract exhibits a pH gradient, with an acidic environment in the stomach and a more alkaline environment in the small intestine. This pH variation directly affects the ionization state of drugs.
A drug's pKa and the pH of the gastrointestinal (GI) tract play crucial roles...
A drug's pKa and the pH of the gastrointestinal (GI) tract play crucial roles...
1.3K
Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism
301
Polymorphism refers to the existence of a drug substance in multiple crystalline forms, known as polymorphs. Recently, this term has been expanded to include solvates (forms containing a solvent), amorphous forms (non-crystalline forms), and desolvated solvates (forms from which the solvent has been removed).
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
301


